Favit-Van Pelt Antonella R. Insider Trades

Insider Trading History

Track insider trading activity for Favit-Van Pelt Antonella R.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Helius Medical Technologies
Helius Medical Technologies HSDT
Chief Medical Officer
Holding Value $24.5k 17,500 shares
Last Trade
Jul 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$171k 17,500 shares
$9.76
$1.40
Helius Medical Technologies
Helius Medical Technologies HSDT
Chief Medical Officer
Holding Value $134k 95,892 shares
Last Trade
Jan 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$52.5M 95,892 shares
$547.00
$1.40
Helius Medical Technologies
Helius Medical Technologies HSDT
Chief Medical Officer
Holding Value $388k 277,000 shares
Last Trade
Jul 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$201M 277,000 shares
$724.00
$1.40
Helius Medical Technologies
Helius Medical Technologies HSDT
Chief Medical Officer
Holding Value $2.05M 1,463,000 shares
Last Trade
Feb 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17B 1,463,000 shares
$11,587.50
$1.40
Helius Medical Technologies
Helius Medical Technologies HSDT
Chief Medical Officer
Holding Value $42k 30,000 shares
Last Trade
Feb 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.27B 30,000 shares
$175,500.00
$1.40
Helius Medical Technologies
Helius Medical Technologies HSDT
Chief Medical Officer
Holding Value $25.2k 18,000 shares
Last Trade
Jul 07, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.1B 18,000 shares
$616,875.00
$1.40

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up